| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
90,643 |
69,954 |
$24.75M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
45,742 |
38,788 |
$10K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
34,213 |
28,774 |
$3K |
| 0012A |
|
811 |
805 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
162 |
144 |
$2K |
| 97802 |
|
3,405 |
3,157 |
$1K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
11,676 |
10,906 |
$632.63 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,162 |
3,978 |
$623.44 |
| 0001A |
|
967 |
949 |
$520.20 |
| 92551 |
|
9,258 |
8,910 |
$515.86 |
| 0011A |
|
993 |
973 |
$480.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,287 |
5,851 |
$461.11 |
| 96151 |
|
1,009 |
861 |
$383.00 |
| 0002A |
|
874 |
854 |
$320.00 |
| 96150 |
|
2,302 |
2,017 |
$276.29 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
122 |
95 |
$227.85 |
| 90688 |
|
761 |
701 |
$203.40 |
| 97803 |
|
2,147 |
1,918 |
$132.60 |
| 99173 |
|
9,038 |
8,688 |
$101.59 |
| 90686 |
|
8,064 |
7,441 |
$21.31 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,841 |
1,527 |
$17.99 |
| 36415 |
Collection of venous blood by venipuncture |
4,861 |
4,379 |
$8.28 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
316 |
276 |
$0.52 |
| 87428 |
|
808 |
650 |
$0.00 |
| 99000 |
|
6,404 |
5,829 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,118 |
1,924 |
$0.00 |
| 3079F |
|
997 |
925 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,063 |
1,971 |
$0.00 |
| 96161 |
|
658 |
628 |
$0.00 |
| 85018 |
|
1,613 |
1,534 |
$0.00 |
| 36416 |
|
308 |
293 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,059 |
1,735 |
$0.00 |
| 90651 |
|
1,523 |
1,476 |
$0.00 |
| 91307 |
|
443 |
423 |
$0.00 |
| 1036F |
|
2,921 |
2,563 |
$0.00 |
| 96156 |
|
2,180 |
2,047 |
$0.00 |
| 1125F |
|
878 |
801 |
$0.00 |
| 90698 |
|
619 |
612 |
$0.00 |
| 91301 |
|
1,198 |
1,171 |
$0.00 |
| 3008F |
|
3,349 |
2,959 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
207 |
197 |
$0.00 |
| 92558 |
|
255 |
250 |
$0.00 |
| 90723 |
|
622 |
582 |
$0.00 |
| 1034F |
|
206 |
170 |
$0.00 |
| 90680 |
|
332 |
314 |
$0.00 |
| 1101F |
|
153 |
142 |
$0.00 |
| H0004 |
Behavioral health counseling and therapy, per 15 minutes |
631 |
326 |
$0.00 |
| 99381 |
|
177 |
161 |
$0.00 |
| 0064A |
|
633 |
609 |
$0.00 |
| 2001F |
|
3,279 |
2,894 |
$0.00 |
| 90696 |
|
203 |
194 |
$0.00 |
| 3075F |
|
434 |
419 |
$0.00 |
| 90716 |
|
171 |
167 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
114 |
90 |
$0.00 |
| 90656 |
|
186 |
174 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
166 |
136 |
$0.00 |
| 0072A |
|
305 |
302 |
$0.00 |
| 91306 |
|
317 |
312 |
$0.00 |
| 1126F |
|
1,567 |
1,465 |
$0.00 |
| 90744 |
|
194 |
192 |
$0.00 |
| 3048F |
|
28 |
26 |
$0.00 |
| 3074F |
|
2,373 |
2,139 |
$0.00 |
| 0134A |
|
256 |
231 |
$0.00 |
| A9150 |
Non-prescription drugs |
285 |
268 |
$0.00 |
| 3044F |
|
27 |
27 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
23 |
22 |
$0.00 |
| 0031A |
|
40 |
40 |
$0.00 |
| 92587 |
|
87 |
76 |
$0.00 |
| 87807 |
|
120 |
104 |
$0.00 |
| 1111F |
|
29 |
29 |
$0.00 |
| 90619 |
|
91 |
91 |
$0.00 |
| 82962 |
|
160 |
137 |
$0.00 |
| 0074A |
|
40 |
40 |
$0.00 |
| 86580 |
|
27 |
25 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
47 |
46 |
$0.00 |
| 3080F |
|
14 |
14 |
$0.00 |
| 90620 |
|
45 |
45 |
$0.00 |
| 99383 |
|
17 |
15 |
$0.00 |
| 0111A |
|
18 |
12 |
$0.00 |
| 85027 |
|
17 |
13 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,580 |
3,364 |
$0.00 |
| 90715 |
|
646 |
600 |
$0.00 |
| 81002 |
|
1,370 |
1,233 |
$0.00 |
| 1159F |
|
2,532 |
2,257 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
288 |
262 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,932 |
2,837 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
219 |
203 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,393 |
3,182 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,107 |
3,968 |
$0.00 |
| 81003 |
|
423 |
378 |
$0.00 |
| 90633 |
|
1,385 |
1,318 |
$0.00 |
| 83655 |
|
1,071 |
1,017 |
$0.00 |
| 90734 |
|
899 |
863 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
853 |
756 |
$0.00 |
| 3078F |
|
2,120 |
1,927 |
$0.00 |
| 90648 |
|
1,041 |
996 |
$0.00 |
| 96158 |
|
209 |
205 |
$0.00 |
| 3288F |
|
171 |
160 |
$0.00 |
| 3077F |
|
379 |
348 |
$0.00 |
| 81025 |
|
855 |
761 |
$0.00 |
| 90670 |
|
2,744 |
2,600 |
$0.00 |
| 90685 |
|
131 |
120 |
$0.00 |
| 90681 |
|
533 |
499 |
$0.00 |
| 90710 |
|
283 |
267 |
$0.00 |
| 91300 |
|
1,614 |
1,482 |
$0.00 |
| 80305 |
|
19 |
16 |
$0.00 |
| 99177 |
|
665 |
648 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,777 |
1,161 |
$0.00 |
| 99188 |
|
111 |
96 |
$0.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
116 |
103 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
919 |
878 |
$0.00 |
| 90837 |
Psychotherapy, 53 minutes with patient |
417 |
254 |
$0.00 |
| 90662 |
|
119 |
110 |
$0.00 |
| 0004A |
|
70 |
70 |
$0.00 |
| 91313 |
|
50 |
50 |
$0.00 |
| 0124A |
|
68 |
56 |
$0.00 |
| 90707 |
|
133 |
131 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
260 |
244 |
$0.00 |
| 96167 |
|
49 |
47 |
$0.00 |
| 82274 |
|
86 |
79 |
$0.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
33 |
27 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
142 |
142 |
$0.00 |
| 84030 |
|
15 |
13 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
36 |
33 |
$0.00 |
| 0071A |
|
340 |
328 |
$0.00 |
| 0054A |
|
19 |
19 |
$0.00 |
| 90700 |
|
48 |
42 |
$0.00 |
| H0031 |
Mental health assessment, by non-physician |
30 |
26 |
$0.00 |